Caitong International Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.7K Buy
376
+229
+156% +$10.8K 0.01% 534
2025
Q1
$5.74K Buy
+147
New +$5.74K ﹤0.01% 987